| Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy SJ Im, M Hashimoto, MY Gerner, J Lee, HT Kissick, MC Burger, Q Shan, ... Nature 537 (7620), 417-421, 2016 | 2238 | 2016 |
| An intra-tumoral niche maintains and differentiates stem-like CD8 T cells CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ... Nature 576 (7787), 465-470, 2019 | 866 | 2019 |
| Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection WH Hudson, J Gensheimer, M Hashimoto, A Wieland, RM Valanparambil, ... Immunity 51 (6), 1043-1058. e4, 2019 | 732 | 2019 |
| CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions M Hashimoto, AO Kamphorst, SJ Im, HT Kissick, RN Pillai, ... Annual review of medicine 69 (1), 301-318, 2018 | 722 | 2018 |
| Origin and differentiation of human memory CD8 T cells after vaccination RS Akondy, M Fitch, S Edupuganti, S Yang, HT Kissick, KW Li, ... Nature 552 (7685), 362-367, 2017 | 621 | 2017 |
| Effector CD8 T cells dedifferentiate into long-lived memory cells B Youngblood, JS Hale, HT Kissick, E Ahn, X Xu, A Wieland, K Araki, ... Nature 552 (7685), 404-409, 2017 | 595 | 2017 |
| Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination AH Ellebedy, KJL Jackson, HT Kissick, HI Nakaya, CW Davis, KM Roskin, ... Nature immunology 17 (10), 1226-1234, 2016 | 469 | 2016 |
| Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation HT Kissick, MG Sanda, LK Dunn, KL Pellegrini, ST On, JK Noel, ... Proceedings of the National Academy of Sciences 111 (27), 9887-9892, 2014 | 378 | 2014 |
| CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ... Immunity 56 (1), 107-124. e5, 2023 | 346 | 2023 |
| Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer CS Eberhardt, HT Kissick, MR Patel, MA Cardenas, N Prokhnevska, ... Nature 597 (7875), 279-284, 2021 | 324 | 2021 |
| PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program M Hashimoto, K Araki, MA Cardenas, P Li, RR Jadhav, HT Kissick, ... Nature 610 (7930), 173-181, 2022 | 319 | 2022 |
| PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells L Codarri Deak, V Nicolini, M Hashimoto, M Karagianni, PC Schwalie, ... Nature 610 (7930), 161-172, 2022 | 264 | 2022 |
| Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy DM Francis, MP Manspeaker, A Schudel, LF Sestito, MJ O’Melia, ... Science translational medicine 12 (563), eaay3575, 2020 | 251 | 2020 |
| Defining HPV-specific B cell responses in patients with head and neck cancer A Wieland, MR Patel, MA Cardenas, CS Eberhardt, WH Hudson, ... Nature 597 (7875), 274-278, 2021 | 228 | 2021 |
| Reinvigorating exhausted T cells by blockade of the PD-1 pathway J Lee, E Ahn, HT Kissick, R Ahmed Onco Therapeutics 6 (1-2), 2015 | 216 | 2015 |
| Translation is actively regulated during the differentiation of CD8+ effector T cells K Araki, M Morita, AG Bederman, BT Konieczny, HT Kissick, N Sonenberg, ... Nature immunology 18 (9), 1046-1057, 2017 | 177 | 2017 |
| The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, ... Cancer 125 (1), 127-134, 2019 | 169 | 2019 |
| Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, ... BMC cancer 19 (1), 857, 2019 | 133 | 2019 |
| Characterization of human CD8 T cell responses in dengue virus-infected patients from India A Chandele, J Sewatanon, S Gunisetty, M Singla, N Onlamoon, ... Journal of virology 90 (24), 11259-11278, 2016 | 120 | 2016 |
| NAD+ protects against EAE by regulating CD4+ T-cell differentiation SG Tullius, HRC Biefer, S Li, AJ Trachtenberg, K Edtinger, M Quante, ... Nature communications 5 (1), 5101, 2014 | 118 | 2014 |
